Birth control pill interaction study completed for experimental hepatitis c drug
NCT ID NCT07272889
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether taking an experimental hepatitis C medication (bemnifosbuvir/ruzasvir) changes how birth control pills work in the body. 24 healthy women who cannot become pregnant took the hepatitis C drug along with a single dose of a common birth control pill. The goal was to measure drug levels in the blood to see if there is a significant interaction. This is a drug-drug interaction study, not a treatment trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atea Study Site
Québec, Montreal, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New asthma drug candidate enters first human safety tests
- Variety beats repetition: study shows mixing it up improves motor learning
- Pain-Free shots? study tests if preservative is the culprit
- Scientists deliberately infect volunteers with whooping cough to study natural defenses
- Could a nerve channel blocker replace opioids? early study investigates
- New pain pill takes first step: safe in healthy volunteers?